US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NLS Pharmaceutics Ltd.

1.47

+0.04002.80%

Volume:47.44K

Turnover:70.64K

Market Cap:1.72M

PE:-0.22

High:1.53

Open:1.44

Low:1.44

Close:1.43

Loading ...

Overview Company News Filings

NLS Pharmaceutics Ltd. Announces Pricing of Private Placement of up to $1 Million at a 15% Premium to the Market

NLS Pharmaceutics Unveils Promising Data for New Treatments

NLS Pharmaceutics announces preclinical data on DOXA platform

NLS Pharmaceutics- Starting in 2025, NLS Plans to Expand Its Research to Investigate Impact on Ctsh in Animal Models of Neuroinflammation

THOMSON REUTERS

NLS Pharmaceutics: Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for Potential Treatment of Narcolepsy

THOMSON REUTERS

NLS Pharmaceutics Ag -Investigational New Drug (Ind) Application Is Planned for 2026-2027 for Study

THOMSON REUTERS

NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders

NLS Pharmaceutics Unveils Promising Narcolepsy Treatment

NLS Pharmaceutics highlights preclinical program for AEX-41, AEX-2

NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders

NLS Pharmaceutics AG Announces Share Capital Expansion

NLS Pharmaceutics, Kadimastem enter definitive merger agreement

NLS Pharmaceutics Ag: Co & Kadimastem Enter Into a Definitive Merger Agreement

THOMSON REUTERS

NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement

NLS Pharmaceutics Achieves Nasdaq Compliance Milestone

NLS Pharmaceutics regains full compliance with Nasdaq listing rules

NLS Pharmaceutics Ltd Regains Full Compliance With Nasdaq Listing Requirements

THOMSON REUTERS

NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements

NLS Pharmaceutics files to sell 2.75M common shares for holders

NLS Pharmaceutics Strikes Debt Forgiveness Deal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NLSP/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NLSP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLSP\",,,,,undefined,":{"symbol":"NLSP","market":"US","secType":"STK","nameCN":"NLS Pharmaceutics Ltd.","latestPrice":1.47,"timestamp":1745438400000,"preClose":1.43,"halted":0,"volume":47440,"delay":0,"floatShares":586518,"shares":1171900,"eps":-6.585135,"marketStatus":"Pre-Mkt","change":0.04,"latestTime":"04-24 07:05:53 EDT","open":1.44,"high":1.525,"low":1.44,"amount":70642.742704,"amplitude":0.059441,"askPrice":1.52,"askSize":100,"bidPrice":1.3,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6.585135,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745501400000},"marketStatusCode":1,"adr":0,"listingDate":1611896400000,"exchange":"NASDAQ","adjPreClose":1.48,"postHourTrading":{"tag":"盘后","latestPrice":1.49,"preClose":1.47,"latestTime":"18:58 EDT","volume":165,"amount":245.5,"timestamp":1745449132403},"volumeRatio":0.1505811566385349},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLSP\",,,,,undefined,":{"symbol":"NLSP","floatShares":586518,"roa":"-227.76%","roe":"-862.92%","lyrEps":-12.753579,"volumeRatio":0.1505811566385349,"shares":1171900,"dividePrice":0,"high":1.525,"amplitude":0.059441,"preClose":1.43,"low":1.44,"week52Low":1.3,"pbRate":"-0.19","week52High":18.388,"institutionHeld":0,"latestPrice":1.47,"eps":-6.585135,"divideRate":0,"volume":47440,"delay":0,"ttmEps":-6.585135,"open":1.44,"prevYearClose":2.11,"prevWeekClose":1.46,"prevMonthClose":1.54,"prevQuarterClose":1.54,"fiveDayClose":1.5,"twentyDayClose":1.5,"sixtyDayClose":1.81},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NLSP\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2489148477","title":"NLS Pharmaceutics Ltd. Announces Pricing of Private Placement of up to $1 Million at a 15% Premium to the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2489148477","media":"PR Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489148477?lang=en_us&edition=fundamental","pubTime":"2024-12-05 02:15","pubTimestamp":1733336100,"startTime":"0","endTime":"0","summary":"ZURICH, Dec. 4, 2024 /PRNewswire/ -- NLS Pharmaceutics Ltd.   , a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced the pricing of a private placement offering consisting of the issuance and sale of up to 322,580 common shares only, par value CHF 0.80 per share, at a purchase price of $3.10 per common share, for aggregate gross proceeds of up to $1.0 million, subject to shareholder approval. The initial closing of the offering in the amount of $500,000 is expected to occur on or before January 10, 2025, and the subsequent closing of $500,000 may occur, at the election of the purchaser, within 15 days following the Company meeting certain conditions, including the receipt of shareholder approval and the Company's common shares trading for at least ten consecutive trading days above the purchase price of $3.10 which corresponds to an approx. 1","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/T7G4vYeZormqEU_B0flaNw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/fde9ee059f73d4b7a4327022162a9ca0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/T7G4vYeZormqEU_B0flaNw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/fde9ee059f73d4b7a4327022162a9ca0"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nls-pharmaceutics-ltd-announces-pricing-181500420.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nls-pharmaceutics-ltd-announces-pricing-181500420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NLSPW","BK4007","NLSP"],"gpt_icon":0},{"id":"2488091700","title":"NLS Pharmaceutics Unveils Promising Data for New Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2488091700","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488091700?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:28","pubTimestamp":1733232485,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics (NLSP) has released an update. NLS Pharmaceutics has released promising preclinical data for its innovative dual orexin receptor ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-unveils-promising-data-for-new-treatments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-unveils-promising-data-for-new-treatments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2488914973","title":"NLS Pharmaceutics announces preclinical data on DOXA platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2488914973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488914973?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:50","pubTimestamp":1733230222,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics (NLSP) shared preclinical data demonstrating the potential of its dual orexin receptor agonist platform. AEX-41 and AEX-2, two fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nls-pharmaceutics-announces-preclinical-data-on-doxa-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nls-pharmaceutics-announces-preclinical-data-on-doxa-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2488911641","title":"NLS Pharmaceutics- Starting in 2025, NLS Plans to Expand Its Research to Investigate Impact on Ctsh in Animal Models of Neuroinflammation","url":"https://stock-news.laohu8.com/highlight/detail?id=2488911641","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488911641?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:42","pubTimestamp":1733229776,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nFWN3N31AP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2488911614","title":"NLS Pharmaceutics: Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for Potential Treatment of Narcolepsy","url":"https://stock-news.laohu8.com/highlight/detail?id=2488911614","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488911614?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:42","pubTimestamp":1733229776,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nFWN3N31AP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2488891195","title":"NLS Pharmaceutics Ag -Investigational New Drug (Ind) Application Is Planned for 2026-2027 for Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2488891195","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488891195?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:42","pubTimestamp":1733229776,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nFWN3N31AP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2488140659","title":"NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2488140659","media":"ACCESSWIRE","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488140659?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:40","pubTimestamp":1733229600,"startTime":"0","endTime":"0","summary":"ZRICH, SWITZERLAND / ACCESSWIRE / December 3, 2024 / NLS Pharmaceutics Ltd.  , a biopharmaceutical company, is pleased to share preclinical data demonstrating the potential of its dual orexin receptor agonist  platform. AEX-41 and AEX-2, two first-in-class non-sulfonamide DOXAs, are designed to target both orexin-1  and orexin-2  receptors while concurrently inhibiting cathepsins. Cathepsins play significant roles in a variety of physiological processes and may offer a novel therapeutic approach for narcolepsy and other neurological disorders.Key Preclinical Results:The ongoing preclinical study, initiated in October 2024 at the Centre for Neuroscience Research of Lyon, one of Europe's premier neuroscience research centers, has produced compelling data:. Improved Wakefulness and Sleep Architecture: In orexin knockout mice, AEX-41  demonstrated a significant increase in wakefulness and a reduction in REM sleep duration. These effects are crucial for managing the core symptoms of narcole","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MYU32KppGNEDO6afIPEqHA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/05653921e1d228198a0d21d272ff6d19","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MYU32KppGNEDO6afIPEqHA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/05653921e1d228198a0d21d272ff6d19"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nls-pharmaceutics-announces-promising-preclinical-124000104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NLSPW","NLSP"],"gpt_icon":0},{"id":"2484209678","title":"NLS Pharmaceutics Unveils Promising Narcolepsy Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2484209678","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484209678?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:59","pubTimestamp":1731938367,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics (NLSP) has released an update. NLS Pharmaceutics is advancing its preclinical program centered on dual orexin receptor agonists (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-unveils-promising-narcolepsy-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-unveils-promising-narcolepsy-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NLSP"],"gpt_icon":0},{"id":"2484622867","title":"NLS Pharmaceutics highlights preclinical program for AEX-41, AEX-2","url":"https://stock-news.laohu8.com/highlight/detail?id=2484622867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484622867?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:46","pubTimestamp":1731933991,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics (NLSP) provided insights into the preclinical program evaluating its dual orexin receptor agonist platform. AEX-41 and AEX-2, two...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nls-pharmaceutics-highlights-preclinical-program-for-aex-41-aex-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nls-pharmaceutics-highlights-preclinical-program-for-aex-41-aex-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2484624833","title":"NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2484624833","media":"ACCESSWIRE","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484624833?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:30","pubTimestamp":1731933000,"startTime":"0","endTime":"0","summary":"ZRICH, SWITZERLAND / ACCESSWIRE / November 18, 2024 / NLS Pharmaceutics Ltd.  , a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, provided insights today into the preclinical program evaluating its dual orexin receptor agonist  platform. AEX-41 and AEX-2, two first-in-class non-sulfonamide DOXAs, are designed to target both orexin-1  and orexin-2  receptors while concurrently inhibiting cathepsins. This unique approach aims to address the unmet therapeutic needs in narcolepsy and related neurological disorders.The ongoing studies are conducted at the Centre for Neuroscience Research of Lyon, a world-class institution specializing in sleep and neurological research. The experimental framework is designed to explore the therapeutic potential of AEX compounds using an international validated orexin knockout  mouse model of narcolepsy.Promote Wakefulness: Eva","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MYU32KppGNEDO6afIPEqHA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/05653921e1d228198a0d21d272ff6d19","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MYU32KppGNEDO6afIPEqHA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/05653921e1d228198a0d21d272ff6d19"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nls-pharmaceutics-highlights-innovative-preclinical-123000958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NLSPW","NLSP"],"gpt_icon":0},{"id":"2483298531","title":"NLS Pharmaceutics AG Announces Share Capital Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2483298531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483298531?lang=en_us&edition=fundamental","pubTime":"2024-11-16 06:30","pubTimestamp":1731709831,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics (NLSP) has released an update. NLS Pharmaceutics AG, a Kloten-based stock corporation, has announced its share capital details, r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-ag-announces-share-capital-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-ag-announces-share-capital-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NLSP","BK4210","AG"],"gpt_icon":0},{"id":"2481508297","title":"NLS Pharmaceutics, Kadimastem enter definitive merger agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2481508297","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481508297?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:31","pubTimestamp":1730809918,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics regains full compliance with Nasdaq listing rules. NLS Pharmaceutics files to sell 2.75M common shares for holders. NLS Pharmaceutics secures patent in Japan for Mazindol ER","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VaKCXGYM.Q2xBRfnsYVuuQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/4228d494699edc69b7f529ca87ad9ce2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VaKCXGYM.Q2xBRfnsYVuuQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/4228d494699edc69b7f529ca87ad9ce2"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nls-pharmaceutics-kadimastem-enter-definitive-123158594.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nls-pharmaceutics-kadimastem-enter-definitive-123158594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","NLSPW","NLSP"],"gpt_icon":0},{"id":"2480300983","title":"NLS Pharmaceutics Ag: Co & Kadimastem Enter Into a Definitive Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2480300983","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480300983?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:06","pubTimestamp":1730725579,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nFWN3MB13O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2480630483","title":"NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2480630483","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480630483?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721600,"startTime":"0","endTime":"0","summary":"I believe that the merger is an outstanding opportunity to progress our proprietary DOXA platform and help to enhance Kadimastem's portfolio of neurodegenerative and diabetes candidates,″ said Alex Zwyer, Chief Executive Officer of NLS. \"This transaction represents NLS' commitment to delivering value to its shareholders by preserving the value of our legacy assets, including Mazindol, through the contingent value rights agreement, while also providing the opportunity for upside in the combined company with a promising cell therapy technological platfo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MYU32KppGNEDO6afIPEqHA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/05653921e1d228198a0d21d272ff6d19","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MYU32KppGNEDO6afIPEqHA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/05653921e1d228198a0d21d272ff6d19"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nls-pharmaceutics-kadimastem-enter-definitive-120000411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","NLSPW","NLSP"],"gpt_icon":0},{"id":"2478107693","title":"NLS Pharmaceutics Achieves Nasdaq Compliance Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2478107693","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478107693?lang=en_us&edition=fundamental","pubTime":"2024-10-28 20:28","pubTimestamp":1730118520,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics (NLSP) has released an update. NLS Pharmaceutics Ltd. has regained full compliance with Nasdaq’s listing requirements, a move tha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-achieves-nasdaq-compliance-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-achieves-nasdaq-compliance-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","PSQ","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SQQQ","IE00BGHQF748.EUR","QLD",".IXIC","NDAQ","MNQmain","TQQQ","BK4585","BK4112","IE00BKPKM429.USD","LU2095319765.USD","NLSP","BK4007","QID","BK4588","LU2210149790.SGD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2478871109","title":"NLS Pharmaceutics regains full compliance with Nasdaq listing rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2478871109","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478871109?lang=en_us&edition=fundamental","pubTime":"2024-10-28 19:20","pubTimestamp":1730114422,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics (NLSP) has received notice from the Nasdaq Stock Market informing the Company that it has regained full compliance with the bid p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nls-pharmaceutics-regains-full-compliance-with-nasdaq-listing-rules?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nls-pharmaceutics-regains-full-compliance-with-nasdaq-listing-rules?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4112","NDAQ","QLD","BK4585","MNQmain","IE00BGHQF748.EUR","IE00B64PRP62.GBP","NLSP","TQQQ","NQmain","LU2210150020.SGD","QID","PSQ","IE00B3QW5Z07.USD","LU2210149790.SGD","SQQQ",".IXIC","LU2095319765.USD","BK4007","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2478055411","title":"NLS Pharmaceutics Ltd Regains Full Compliance With Nasdaq Listing Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2478055411","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478055411?lang=en_us&edition=fundamental","pubTime":"2024-10-28 19:03","pubTimestamp":1730113402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241028:nFWN3M40Q4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2478106476","title":"NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2478106476","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478106476?lang=en_us&edition=fundamental","pubTime":"2024-10-28 19:00","pubTimestamp":1730113200,"startTime":"0","endTime":"0","summary":"ZURICH, SWITZERLAND / ACCESSWIRE / October 28, 2024 / NLS Pharmaceutics Ltd.  , a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that it has received notice from the Nasdaq Stock Market LLC  informing the Company that it has regained full compliance with the bid price requirement in Listing Rule 5550 and the equity requirement in Listing Rule 5550.\"We are pleased to report that Nasdaq has recognized our full compliance with their listing requirements,\" said Alex Zwyer, Chief Executive Officer of NLS Pharmaceutics. \"Their confirmation follows our successful efforts to improve our balance sheet, including raising new capital and implementing a reverse share split.\". NLS is a global development-stage biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, focused on the discovery a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MYU32KppGNEDO6afIPEqHA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/05653921e1d228198a0d21d272ff6d19","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MYU32KppGNEDO6afIPEqHA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/05653921e1d228198a0d21d272ff6d19"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nls-pharmaceutics-ltd-regains-full-110000793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","BK4588","PSQ","QLD","NDAQ","IE00BGHQF748.EUR","BK4112","TQQQ","IE00BKPKM429.USD","BK4585","NQmain","IE00B3QW5Z07.USD","LU2210149790.SGD","MNQmain","QID","BK4007","IE00B64PRP62.GBP","NLSPW","LU2210150020.SGD",".IXIC","NLSP","SQQQ"],"gpt_icon":1},{"id":"2477561546","title":"NLS Pharmaceutics files to sell 2.75M common shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2477561546","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477561546?lang=en_us&edition=fundamental","pubTime":"2024-10-24 04:06","pubTimestamp":1729714005,"startTime":"0","endTime":"0","summary":"The company will not receive any proceeds from the sale of the common shares by the selling shareholders. Published first on TheFly – the ultimate ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nls-pharmaceutics-files-to-sell-2-75m-common-shares-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nls-pharmaceutics-files-to-sell-2-75m-common-shares-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2477395584","title":"NLS Pharmaceutics Strikes Debt Forgiveness Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2477395584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477395584?lang=en_us&edition=fundamental","pubTime":"2024-10-23 04:33","pubTimestamp":1729629184,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics (NLSP) has released an update. NLS Pharmaceutics has entered into a debt forgiveness agreement where a lender has agreed to forgi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-strikes-debt-forgiveness-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-strikes-debt-forgiveness-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NLSP","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":61,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NLSP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-27","symbol":"NLSP","defaultRemindTime":1727443800000,"type":"split","dateTimestamp":1727409600000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NLSP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NLSP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NLSP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NLSP","date":"2025-04-23","current":-0.351752,"percent":0.993224,"low":-21.132656,"twenty":-4.272371,"median":-1.506489,"eighty":-0.626317,"high":-0.319775,"avg":-3.302548,"sd":4.14816,"marketCap":2319850},"quantilePoints":[{"date":"2021-01-29","current":-6.162298,"twenty":-6.162298,"median":-6.162298,"eighty":-6.162298,"marketCap":20114400},{"date":"2021-02-05","current":-11.006623,"twenty":-11.620107,"median":-10.591619,"eighty":-9.454869,"marketCap":35926794},{"date":"2021-02-12","current":-12.462848,"twenty":-11.728369,"median":-11.018964,"eighty":-10.176615,"marketCap":40680071},{"date":"2021-02-19","current":-11.95711,"twenty":-12.036583,"median":-11.27075,"eighty":-10.696272,"marketCap":39029285},{"date":"2021-02-26","current":-10.331521,"twenty":-11.97156,"median":-11.126253,"eighty":-10.649125,"marketCap":33723189},{"date":"2021-03-05","current":-8.236317,"twenty":-11.783714,"median":-11.006623,"eighty":-10.213841,"marketCap":26884221},{"date":"2021-03-12","current":-21.132656,"twenty":-11.783714,"median":-10.831723,"eighty":-9.607103,"marketCap":68979251},{"date":"2021-03-19","current":-14.991542,"twenty":-12.520647,"median":-11.018964,"eighty":-10.070324,"marketCap":48933998},{"date":"2021-03-26","current":-13.618823,"twenty":-13.683847,"median":-11.234625,"eighty":-10.184942,"marketCap":44453295},{"date":"2021-04-01","current":-14.88317,"twenty":-14.355756,"median":-11.674238,"eighty":-10.208698,"marketCap":48580259},{"date":"2021-04-09","current":-13.980065,"twenty":-14.19681,"median":-11.95711,"eighty":-10.288172,"marketCap":45632427},{"date":"2021-04-16","current":-11.559744,"twenty":-14.153461,"median":-11.812613,"eighty":-10.569724,"marketCap":37732240},{"date":"2021-04-23","current":-12.896339,"twenty":-14.081212,"median":-11.740365,"eighty":-10.641972,"marketCap":42095030},{"date":"2021-04-30","current":-13.221457,"twenty":-14.052313,"median":-11.920986,"eighty":-10.772091,"marketCap":43156249},{"date":"2021-05-07","current":-12.282228,"twenty":-14.008964,"median":-11.95711,"eighty":-10.801135,"marketCap":40090505},{"date":"2021-05-14","current":-14.171062,"twenty":-14.008964,"median":-11.920986,"eighty":-10.816166,"marketCap":40549572},{"date":"2021-05-21","current":-14.550644,"twenty":-14.181361,"median":-12.137731,"eighty":-10.83283,"marketCap":41635721},{"date":"2021-05-28","current":-14.550644,"twenty":-14.424117,"median":-12.318352,"eighty":-10.83726,"marketCap":41635721},{"date":"2021-06-04","current":-14.044534,"twenty":-14.339765,"median":-12.607345,"eighty":-10.905005,"marketCap":40187522},{"date":"2021-06-11","current":-14.381941,"twenty":-14.483163,"median":-12.896339,"eighty":-11.011559,"marketCap":41152988},{"date":"2021-06-18","current":-12.905788,"twenty":-14.365071,"median":-12.937188,"eighty":-11.03298,"marketCap":36929074},{"date":"2021-06-25","current":-13.707128,"twenty":-14.339765,"median":-13.032316,"eighty":-11.054005,"marketCap":39222056},{"date":"2021-07-02","current":-13.222106,"twenty":-14.339765,"median":-13.201019,"eighty":-11.111803,"marketCap":37834198},{"date":"2021-07-09","current":-12.99014,"twenty":-14.314459,"median":-13.090762,"eighty":-11.198501,"marketCap":37170441},{"date":"2021-07-16","current":-12.947964,"twenty":-14.209952,"median":-13.032316,"eighty":-11.212951,"marketCap":37049757},{"date":"2021-07-23","current":-12.357503,"twenty":-14.19681,"median":-12.99014,"eighty":-11.27075,"marketCap":35360192},{"date":"2021-07-30","current":-10.965703,"twenty":-14.19166,"median":-12.968587,"eighty":-11.212951,"marketCap":31377645},{"date":"2021-08-06","current":-10.783503,"twenty":-14.171062,"median":-12.905788,"eighty":-11.054005,"marketCap":30856293},{"date":"2021-08-13","current":-9.953484,"twenty":-14.162627,"median":-12.896339,"eighty":-11.025182,"marketCap":28481247},{"date":"2021-08-20","current":-9.700429,"twenty":-14.128886,"median":-12.787966,"eighty":-10.856045,"marketCap":27757147},{"date":"2021-08-27","current":-10.206538,"twenty":-14.128021,"median":-12.694909,"eighty":-10.806145,"marketCap":29205346},{"date":"2021-09-03","current":-11.176581,"twenty":-14.110111,"median":-12.452351,"eighty":-10.797826,"marketCap":31981061},{"date":"2021-09-10","current":-11.640515,"twenty":-14.052313,"median":-12.355989,"eighty":-10.801135,"marketCap":33308577},{"date":"2021-09-17","current":-11.09223,"twenty":-14.052313,"median":-12.282228,"eighty":-10.801135,"marketCap":31739694},{"date":"2021-09-24","current":-10.923526,"twenty":-14.044534,"median":-12.083545,"eighty":-10.796999,"marketCap":31256961},{"date":"2021-10-01","current":-4.821474,"twenty":-14.002359,"median":-11.884861,"eighty":-10.728526,"marketCap":30050129},{"date":"2021-10-08","current":-4.763384,"twenty":-13.980065,"median":-11.850246,"eighty":-10.512142,"marketCap":29688079},{"date":"2021-10-15","current":-4.666567,"twenty":-13.943941,"median":-11.740365,"eighty":-10.331521,"marketCap":29084663},{"date":"2021-10-22","current":-4.947861,"twenty":-13.799444,"median":-11.726617,"eighty":-10.176615,"marketCap":30837848},{"date":"2021-10-29","current":-4.646687,"twenty":-13.707128,"median":-11.640515,"eighty":-9.99566,"marketCap":28960761},{"date":"2021-11-05","current":-4.625175,"twenty":-13.654947,"median":-11.609223,"eighty":-9.700429,"marketCap":28826684},{"date":"2021-11-12","current":-4.560637,"twenty":-13.622776,"median":-11.559744,"eighty":-9.645161,"marketCap":28424451},{"date":"2021-11-19","current":-4.216438,"twenty":-13.618823,"median":-11.38746,"eighty":-8.489186,"marketCap":26279209},{"date":"2021-11-26","current":-4.330454,"twenty":-13.561024,"median":-11.308017,"eighty":-5.001323,"marketCap":26989820},{"date":"2021-12-03","current":-3.170934,"twenty":-13.517675,"median":-11.218757,"eighty":-4.926036,"marketCap":19763038},{"date":"2021-12-10","current":-3.099943,"twenty":-13.452652,"median":-11.187541,"eighty":-4.840837,"marketCap":19320582},{"date":"2021-12-17","current":-3.099943,"twenty":-13.383418,"median":-11.134406,"eighty":-4.818787,"marketCap":19320582},{"date":"2021-12-23","current":-3.170934,"twenty":-13.369722,"median":-11.09223,"eighty":-4.80211,"marketCap":19763038},{"date":"2021-12-31","current":-2.626669,"twenty":-13.293805,"median":-11.054005,"eighty":-4.763384,"marketCap":16370874},{"date":"2022-01-07","current":-2.886969,"twenty":-13.243194,"median":-11.018964,"eighty":-4.681107,"marketCap":17993213},{"date":"2022-01-14","current":-2.579342,"twenty":-13.243194,"median":-10.944615,"eighty":-4.666567,"marketCap":16075904},{"date":"2022-01-21","current":-2.224386,"twenty":-13.234759,"median":-10.923526,"eighty":-4.63378,"marketCap":13863623},{"date":"2022-01-28","current":-1.987749,"twenty":-13.221846,"median":-10.83726,"eighty":-4.522646,"marketCap":12388770},{"date":"2022-02-04","current":-2.149846,"twenty":-13.221457,"median":-10.813661,"eighty":-4.326582,"marketCap":13399044},{"date":"2022-02-11","current":-2.43736,"twenty":-13.213282,"median":-10.796999,"eighty":-4.160076,"marketCap":15190992},{"date":"2022-02-18","current":-2.839642,"twenty":-13.201019,"median":-10.769163,"eighty":-3.710466,"marketCap":17698243},{"date":"2022-02-25","current":-2.671867,"twenty":-13.201019,"median":-10.741675,"eighty":-3.265588,"marketCap":16652571},{"date":"2022-03-04","current":-3.383907,"twenty":-13.190657,"median":-10.712648,"eighty":-3.180399,"marketCap":21090406},{"date":"2022-03-11","current":-3.241925,"twenty":-13.134265,"median":-10.485868,"eighty":-3.180399,"marketCap":20205494},{"date":"2022-03-18","current":-2.934297,"twenty":-13.066056,"median":-10.375241,"eighty":-3.133072,"marketCap":18288184},{"date":"2022-03-25","current":-1.753121,"twenty":-13.032316,"median":-10.214843,"eighty":-3.099943,"marketCap":20942921},{"date":"2022-04-01","current":-1.679045,"twenty":-13.023881,"median":-10.176615,"eighty":-3.076279,"marketCap":20058008},{"date":"2022-04-08","current":-1.456819,"twenty":-12.99014,"median":-10.058923,"eighty":-3.005335,"marketCap":17403272},{"date":"2022-04-14","current":-1.546489,"twenty":-12.99014,"median":-9.974572,"eighty":-2.957961,"marketCap":18474476},{"date":"2022-04-22","current":-1.516749,"twenty":-12.99014,"median":-9.869132,"eighty":-2.930984,"marketCap":18119198},{"date":"2022-04-29","current":-1.577433,"twenty":-12.968587,"median":-9.700429,"eighty":-2.839642,"marketCap":18844132},{"date":"2022-05-06","current":-1.177691,"twenty":-12.947964,"median":-9.645161,"eighty":-2.815978,"marketCap":14068790},{"date":"2022-05-13","current":-1.067449,"twenty":-12.905788,"median":-9.085235,"eighty":-2.673996,"marketCap":12751833},{"date":"2022-05-20","current":-1.044444,"twenty":-12.905788,"median":-8.236317,"eighty":-2.662165,"marketCap":12477009},{"date":"2022-05-27","current":-1.196648,"twenty":-12.905788,"median":-4.984708,"eighty":-2.532014,"marketCap":14295245},{"date":"2022-06-03","current":-1.25186,"twenty":-12.898229,"median":-4.952439,"eighty":-2.498885,"marketCap":14954822},{"date":"2022-06-10","current":-0.908566,"twenty":-12.870157,"median":-4.879564,"eighty":-2.432627,"marketCap":10853795},{"date":"2022-06-17","current":-0.854657,"twenty":-12.831994,"median":-4.851324,"eighty":-2.262248,"marketCap":10209803},{"date":"2022-06-24","current":-0.923708,"twenty":-12.780741,"median":-4.840568,"eighty":-2.178668,"marketCap":11034691},{"date":"2022-07-01","current":-0.803323,"twenty":-12.717682,"median":-4.818787,"eighty":-2.044542,"marketCap":9596564},{"date":"2022-07-08","current":-0.953994,"twenty":-12.694909,"median":-4.803728,"eighty":-1.843079,"marketCap":11396485},{"date":"2022-07-15","current":-0.966865,"twenty":-12.678039,"median":-4.792428,"eighty":-1.683897,"marketCap":11550247},{"date":"2022-07-22","current":-0.652653,"twenty":-12.57678,"median":-4.763384,"eighty":-1.645772,"marketCap":7796643},{"date":"2022-07-29","current":-0.559979,"twenty":-12.454451,"median":-4.743493,"eighty":-1.584496,"marketCap":6689555},{"date":"2022-08-05","current":-0.609042,"twenty":-12.408114,"median":-4.6682,"eighty":-1.550695,"marketCap":7275660},{"date":"2022-08-12","current":-0.651593,"twenty":-12.356292,"median":-4.667383,"eighty":-1.509983,"marketCap":7783980},{"date":"2022-08-19","current":-0.752595,"twenty":-12.338816,"median":-4.647204,"eighty":-1.456819,"marketCap":8990560},{"date":"2022-08-26","current":-0.769858,"twenty":-12.302087,"median":-4.597462,"eighty":-1.38638,"marketCap":9196782},{"date":"2022-09-02","current":-0.802566,"twenty":-12.253328,"median":-4.539125,"eighty":-1.270007,"marketCap":9587519},{"date":"2022-09-09","current":-1.342708,"twenty":-12.195529,"median":-4.4961,"eighty":-1.253627,"marketCap":16040100},{"date":"2022-09-16","current":-1.465007,"twenty":-12.116056,"median":-4.327227,"eighty":-1.262046,"marketCap":17501084},{"date":"2022-09-23","current":-1.458493,"twenty":-12.014908,"median":-4.216438,"eighty":-1.270754,"marketCap":17423276},{"date":"2022-09-30","current":-1.009563,"twenty":-11.94266,"median":-4.152976,"eighty":-1.251566,"marketCap":12060323},{"date":"2022-10-07","current":-1.074696,"twenty":-11.878168,"median":-3.893752,"eighty":-1.196058,"marketCap":12838408},{"date":"2022-10-14","current":-0.632845,"twenty":-11.851394,"median":-3.573217,"eighty":-1.179921,"marketCap":10115109},{"date":"2022-10-21","current":-0.583191,"twenty":-11.850935,"median":-3.454898,"eighty":-1.156915,"marketCap":9321462},{"date":"2022-10-28","current":-0.905616,"twenty":-11.834576,"median":-3.348412,"eighty":-1.143349,"marketCap":14474959},{"date":"2022-11-04","current":-0.936321,"twenty":-11.769264,"median":-3.265588,"eighty":-1.1279,"marketCap":14965729},{"date":"2022-11-11","current":-0.832132,"twenty":-11.740365,"median":-3.24015,"eighty":-1.069487,"marketCap":13300419},{"date":"2022-11-18","current":-1.016015,"twenty":-11.737966,"median":-3.170934,"eighty":-1.064504,"marketCap":16239525},{"date":"2022-11-25","current":-1.414486,"twenty":-11.728369,"median":-3.123606,"eighty":-1.05569,"marketCap":22608507},{"date":"2022-12-02","current":-1.457439,"twenty":-11.724866,"median":-3.099943,"eighty":-1.063768,"marketCap":23295034},{"date":"2022-12-09","current":-1.494326,"twenty":-11.668116,"median":-3.076279,"eighty":-1.067449,"marketCap":23884634},{"date":"2022-12-16","current":-2.075105,"twenty":-11.640515,"median":-3.064447,"eighty":-1.067449,"marketCap":33167528},{"date":"2022-12-23","current":-2.658793,"twenty":-11.631992,"median":-3.005525,"eighty":-1.067633,"marketCap":42496933},{"date":"2022-12-30","current":-2.679565,"twenty":-11.622484,"median":-3.005288,"eighty":-1.068075,"marketCap":42828940},{"date":"2023-01-06","current":-3.510437,"twenty":-11.607046,"median":-2.97037,"eighty":-1.072092,"marketCap":56109232},{"date":"2023-01-13","current":-3.489695,"twenty":-11.575182,"median":-3.005407,"eighty":-1.089351,"marketCap":55777695},{"date":"2023-01-20","current":-2.901316,"twenty":-11.559744,"median":-2.987829,"eighty":-1.101338,"marketCap":46373316},{"date":"2023-01-27","current":-2.99691,"twenty":-11.558312,"median":-3.005288,"eighty":-1.113336,"marketCap":47901242},{"date":"2023-02-03","current":-2.883887,"twenty":-11.488682,"median":-3.001099,"eighty":-1.129458,"marketCap":46094735},{"date":"2023-02-10","current":-2.902123,"twenty":-11.38746,"median":-2.990124,"eighty":-1.136905,"marketCap":46386217},{"date":"2023-02-17","current":-2.968707,"twenty":-11.37059,"median":-2.96925,"eighty":-1.141288,"marketCap":47450463},{"date":"2023-02-24","current":-2.968707,"twenty":-11.330377,"median":-2.968707,"eighty":-1.143349,"marketCap":47450463},{"date":"2023-03-03","current":-2.968707,"twenty":-11.27075,"median":-2.968707,"eighty":-1.150711,"marketCap":47450463},{"date":"2023-03-10","current":-3.286783,"twenty":-11.260351,"median":-2.970081,"eighty":-1.15314,"marketCap":52534441},{"date":"2023-03-17","current":-3.180758,"twenty":-11.214706,"median":-2.99691,"eighty":-1.155887,"marketCap":50839782},{"date":"2023-03-24","current":-2.677138,"twenty":-11.198501,"median":-2.980247,"eighty":-1.156915,"marketCap":42790149},{"date":"2023-03-31","current":-3.223168,"twenty":-11.194117,"median":-2.97037,"eighty":-1.162089,"marketCap":51517645},{"date":"2023-04-06","current":-3.286783,"twenty":-11.176581,"median":-2.99691,"eighty":-1.172559,"marketCap":52534441},{"date":"2023-04-14","current":-3.307988,"twenty":-11.134406,"median":-3.005407,"eighty":-1.177691,"marketCap":52873373},{"date":"2023-04-21","current":-3.180758,"twenty":-11.134406,"median":-3.011117,"eighty":-1.177691,"marketCap":50839782},{"date":"2023-04-28","current":-3.06413,"twenty":-11.100665,"median":-3.032322,"eighty":-1.186612,"marketCap":48975656},{"date":"2023-05-05","current":-2.694314,"twenty":-11.09223,"median":-3.011117,"eighty":-1.191708,"marketCap":43064684},{"date":"2023-05-12","current":-2.587016,"twenty":-11.09223,"median":-3.005288,"eighty":-1.192564,"marketCap":41349689},{"date":"2023-05-19","current":-2.260138,"twenty":-11.069295,"median":-2.99691,"eighty":-1.194586,"marketCap":37282506},{"date":"2023-05-26","current":-2.167677,"twenty":-11.054005,"median":-2.970081,"eighty":-1.196353,"marketCap":35757313},{"date":"2023-06-02","current":-2.018588,"twenty":-11.052425,"median":-2.968707,"eighty":-1.20055,"marketCap":33297987},{"date":"2023-06-09","current":-1.822784,"twenty":-11.037618,"median":-2.968707,"eighty":-1.210581,"marketCap":30068069},{"date":"2023-06-16","current":-1.906925,"twenty":-11.016496,"median":-2.968707,"eighty":-1.221877,"marketCap":31456026},{"date":"2023-06-23","current":-2.024879,"twenty":-11.009091,"median":-2.963334,"eighty":-1.23696,"marketCap":33401759},{"date":"2023-06-30","current":-1.80863,"twenty":-10.982071,"median":-2.956973,"eighty":-1.24769,"marketCap":29834581},{"date":"2023-07-07","current":-2.339424,"twenty":-10.948832,"median":-2.947502,"eighty":-1.251639,"marketCap":38590382},{"date":"2023-07-14","current":-1.80863,"twenty":-10.923526,"median":-2.947502,"eighty":-1.255394,"marketCap":29834581},{"date":"2023-07-21","current":-1.727438,"twenty":-10.923526,"median":-2.947171,"eighty":-1.263397,"marketCap":28495268},{"date":"2023-07-28","current":-1.866624,"twenty":-10.889786,"median":-2.934297,"eighty":-1.271065,"marketCap":30791233},{"date":"2023-08-04","current":-1.729994,"twenty":-10.838409,"median":-2.926297,"eighty":-1.279483,"marketCap":28537425},{"date":"2023-08-11","current":-1.688513,"twenty":-10.83726,"median":-2.910633,"eighty":-1.284028,"marketCap":27853176},{"date":"2023-08-18","current":-1.602997,"twenty":-10.83283,"median":-2.908055,"eighty":-1.288992,"marketCap":26442519},{"date":"2023-08-25","current":-1.631699,"twenty":-10.816166,"median":-2.905092,"eighty":-1.314876,"marketCap":26915981},{"date":"2023-09-01","current":-2.00522,"twenty":-10.801135,"median":-2.901316,"eighty":-1.345188,"marketCap":33077470},{"date":"2023-09-08","current":-1.812562,"twenty":-10.801135,"median":-2.883887,"eighty":-1.355109,"marketCap":29899439},{"date":"2023-09-15","current":-1.709352,"twenty":-10.796999,"median":-2.852079,"eighty":-1.376458,"marketCap":28196922},{"date":"2023-09-22","current":-1.572722,"twenty":-10.796999,"median":-2.841477,"eighty":-1.392383,"marketCap":25943114},{"date":"2023-09-29","current":-1.367285,"twenty":-10.783503,"median":-2.829957,"eighty":-1.392383,"marketCap":22554295},{"date":"2023-10-06","current":-1.45752,"twenty":-10.754823,"median":-2.815978,"eighty":-1.392383,"marketCap":24042781},{"date":"2023-10-13","current":-1.494086,"twenty":-10.754823,"median":-2.791948,"eighty":-1.395791,"marketCap":24645958},{"date":"2023-10-20","current":-1.488974,"twenty":-10.728526,"median":-2.756657,"eighty":-1.401262,"marketCap":24561643},{"date":"2023-10-27","current":-1.060014,"twenty":-10.722175,"median":-2.741237,"eighty":-1.393746,"marketCap":17485659},{"date":"2023-11-03","current":-1.297889,"twenty":-10.712648,"median":-2.717785,"eighty":-1.370824,"marketCap":21409555},{"date":"2023-11-10","current":-1.376132,"twenty":-10.678907,"median":-2.694314,"eighty":-1.355654,"marketCap":22700225},{"date":"2023-11-17","current":-0.629089,"twenty":-10.581834,"median":-2.679565,"eighty":-1.301585,"marketCap":10377245},{"date":"2023-11-24","current":-0.786754,"twenty":-10.501632,"median":-2.675567,"eighty":-1.296557,"marketCap":12978042},{"date":"2023-12-01","current":-0.825482,"twenty":-10.451158,"median":-2.673996,"eighty":-1.269257,"marketCap":13616892},{"date":"2023-12-08","current":-0.914538,"twenty":-10.408982,"median":-2.660479,"eighty":-1.258099,"marketCap":15085921},{"date":"2023-12-15","current":-0.886219,"twenty":-10.366497,"median":-2.638021,"eighty":-1.221877,"marketCap":13707693},{"date":"2023-12-22","current":-0.933602,"twenty":-10.309846,"median":-2.611573,"eighty":-1.196058,"marketCap":14440586},{"date":"2023-12-29","current":-1.060654,"twenty":-10.244823,"median":-2.596477,"eighty":-1.191708,"marketCap":16405776},{"date":"2024-01-05","current":-1.19106,"twenty":-10.216504,"median":-2.583179,"eighty":-1.189729,"marketCap":18422854},{"date":"2024-01-12","current":-1.06925,"twenty":-10.198732,"median":-2.532014,"eighty":-1.174078,"marketCap":16538735},{"date":"2024-01-19","current":-1.006353,"twenty":-10.184942,"median":-2.508351,"eighty":-1.156915,"marketCap":15565868},{"date":"2024-01-26","current":-0.979307,"twenty":-10.174165,"median":-2.461023,"eighty":-1.143349,"marketCap":15147535},{"date":"2024-02-02","current":-1.048284,"twenty":-10.147493,"median":-2.43736,"eighty":-1.109,"marketCap":16214446},{"date":"2024-02-09","current":-1.048284,"twenty":-10.071576,"median":-2.3937,"eighty":-1.083826,"marketCap":16214446},{"date":"2024-02-16","current":-0.943435,"twenty":-10.0294,"median":-2.359083,"eighty":-1.067743,"marketCap":14592677},{"date":"2024-02-23","current":-0.859593,"twenty":-9.99566,"median":-2.339424,"eighty":-1.063768,"marketCap":13295846},{"date":"2024-03-01","current":-0.810952,"twenty":-9.953484,"median":-2.276199,"eighty":-1.048284,"marketCap":12543495},{"date":"2024-03-08","current":-0.744282,"twenty":-9.911308,"median":-2.260138,"eighty":-1.047065,"marketCap":11512257},{"date":"2024-03-15","current":-0.786397,"twenty":-9.869132,"median":-2.216578,"eighty":-1.027318,"marketCap":12163689},{"date":"2024-03-22","current":-0.398952,"twenty":-9.700429,"median":-2.198497,"eighty":-1.016015,"marketCap":6170829},{"date":"2024-03-28","current":-0.462398,"twenty":-9.700429,"median":-2.167677,"eighty":-1.006353,"marketCap":7152191},{"date":"2024-04-05","current":-0.43187,"twenty":-9.700429,"median":-2.158837,"eighty":-1.005766,"marketCap":6679999},{"date":"2024-04-12","current":-0.43005,"twenty":-9.666688,"median":-2.136857,"eighty":-1.000713,"marketCap":6651841},{"date":"2024-04-19","current":-0.404444,"twenty":-9.647779,"median":-2.113345,"eighty":-0.985387,"marketCap":6255787},{"date":"2024-04-26","current":-0.40353,"twenty":-9.492927,"median":-2.084053,"eighty":-0.972901,"marketCap":6241644},{"date":"2024-05-03","current":-0.414502,"twenty":-9.26031,"median":-2.078755,"eighty":-0.965677,"marketCap":6411357},{"date":"2024-05-10","current":-0.431265,"twenty":-9.009375,"median":-2.024879,"eighty":-0.964304,"marketCap":6670639},{"date":"2024-05-17","current":-0.455343,"twenty":-8.583109,"median":-2.00522,"eighty":-0.961435,"marketCap":7043064},{"date":"2024-05-24","current":-0.671385,"twenty":-8.286891,"median":-1.978757,"eighty":-0.951327,"marketCap":8172123},{"date":"2024-05-31","current":-0.643693,"twenty":-6.991906,"median":-1.965902,"eighty":-0.939852,"marketCap":7835055},{"date":"2024-06-07","current":-0.510462,"twenty":-5.472359,"median":-1.926585,"eighty":-0.928251,"marketCap":6213359},{"date":"2024-06-14","current":-0.383218,"twenty":-4.990246,"median":-1.921571,"eighty":-0.92249,"marketCap":4664538},{"date":"2024-06-21","current":-0.61638,"twenty":-4.957017,"median":-1.907023,"eighty":-0.914646,"marketCap":7502601},{"date":"2024-06-28","current":-0.7915,"twenty":-4.957017,"median":-1.906925,"eighty":-0.913391,"marketCap":9634159},{"date":"2024-07-05","current":-0.665519,"twenty":-4.953355,"median":-1.905942,"eighty":-0.908626,"marketCap":8100722},{"date":"2024-07-12","current":-0.676073,"twenty":-4.943778,"median":-1.86918,"eighty":-0.901027,"marketCap":8229177},{"date":"2024-07-15","current":-0.70916,"twenty":-4.941737,"median":-1.867902,"eighty":-0.899992,"marketCap":8631912},{"date":"2024-08-02","current":-0.741264,"twenty":-4.939695,"median":-1.866624,"eighty":-0.897385,"marketCap":9022692},{"date":"2024-08-09","current":-0.689187,"twenty":-4.891182,"median":-1.823374,"eighty":-0.88859,"marketCap":8388803},{"date":"2024-08-16","current":-0.610705,"twenty":-4.865362,"median":-1.812562,"eighty":-0.882748,"marketCap":7433517},{"date":"2024-08-23","current":-0.634248,"twenty":-4.861812,"median":-1.808531,"eighty":-0.877583,"marketCap":7720090},{"date":"2024-08-30","current":-0.539004,"twenty":-4.845032,"median":-1.7988,"eighty":-0.861912,"marketCap":6560774},{"date":"2024-09-06","current":-0.506899,"twenty":-4.840837,"median":-1.788971,"eighty":-0.852113,"marketCap":6169993},{"date":"2024-09-13","current":-0.470871,"twenty":-4.840514,"median":-1.779252,"eighty":-0.831376,"marketCap":5731450},{"date":"2024-09-20","current":-0.48835,"twenty":-4.829004,"median":-1.769115,"eighty":-0.81762,"marketCap":5944209},{"date":"2024-09-27","current":-0.4459,"twenty":-4.819862,"median":-1.760037,"eighty":-0.809409,"marketCap":5427510},{"date":"2024-10-04","current":-0.434788,"twenty":-4.818787,"median":-1.749456,"eighty":-0.802566,"marketCap":5292256},{"date":"2024-10-11","current":-0.379015,"twenty":-4.809752,"median":-1.732746,"eighty":-0.786754,"marketCap":4613383},{"date":"2024-10-18","current":-0.461953,"twenty":-4.802757,"median":-1.727438,"eighty":-0.774201,"marketCap":5622900},{"date":"2024-10-25","current":-1.225578,"twenty":-4.80211,"median":-1.713877,"eighty":-0.774201,"marketCap":8082838},{"date":"2024-10-31","current":-1.1105,"twenty":-4.794365,"median":-1.709745,"eighty":-0.778597,"marketCap":7323886},{"date":"2024-11-08","current":-1.193931,"twenty":-4.775002,"median":-1.695984,"eighty":-0.785429,"marketCap":7874127},{"date":"2024-11-15","current":-0.960899,"twenty":-4.763384,"median":-1.691024,"eighty":-0.78654,"marketCap":6337249},{"date":"2024-11-22","current":-0.968091,"twenty":-4.763384,"median":-1.686547,"eighty":-0.786754,"marketCap":6384683},{"date":"2024-11-29","current":-0.972407,"twenty":-4.761557,"median":-1.679045,"eighty":-0.787344,"marketCap":6413144},{"date":"2024-12-06","current":-0.647312,"twenty":-4.749947,"median":-1.668465,"eighty":-0.786468,"marketCap":4269105},{"date":"2024-12-13","current":-0.482122,"twenty":-4.724132,"median":-1.659221,"eighty":-0.775508,"marketCap":3179655},{"date":"2024-12-20","current":-0.585434,"twenty":-4.68541,"median":-1.651388,"eighty":-0.770766,"marketCap":3861009},{"date":"2024-12-27","current":-0.457524,"twenty":-4.6682,"median":-1.645897,"eighty":-0.761733,"marketCap":3017427},{"date":"2025-01-03","current":-0.536238,"twenty":-4.6682,"median":-1.636024,"eighty":-0.749567,"marketCap":3536555},{"date":"2025-01-10","current":-0.592813,"twenty":-4.6682,"median":-1.631718,"eighty":-0.747047,"marketCap":3909677},{"date":"2025-01-17","current":-0.5018,"twenty":-4.66722,"median":-1.630323,"eighty":-0.741703,"marketCap":3309436},{"date":"2025-01-24","current":-0.457524,"twenty":-4.666567,"median":-1.614006,"eighty":-0.729372,"marketCap":3017427},{"date":"2025-01-31","current":-0.487042,"twenty":-4.658822,"median":-1.612138,"eighty":-0.712569,"marketCap":3212100},{"date":"2025-02-07","current":-0.474742,"twenty":-4.646997,"median":-1.602997,"eighty":-0.695074,"marketCap":3130986},{"date":"2025-02-14","current":-0.565755,"twenty":-4.638082,"median":-1.584927,"eighty":-0.68556,"marketCap":3731227},{"date":"2025-02-21","current":-0.50426,"twenty":-4.61409,"median":-1.57882,"eighty":-0.67429,"marketCap":3325659},{"date":"2025-02-28","current":-0.447685,"twenty":-4.567927,"median":-1.572722,"eighty":-0.67154,"marketCap":2952536},{"date":"2025-03-07","current":-0.403408,"twenty":-4.556335,"median":-1.561266,"eighty":-0.665519,"marketCap":2660527},{"date":"2025-03-14","current":-0.37635,"twenty":-4.533632,"median":-1.557004,"eighty":-0.654678,"marketCap":2482077},{"date":"2025-03-21","current":-0.368971,"twenty":-4.508548,"median":-1.535861,"eighty":-0.647326,"marketCap":2433409},{"date":"2025-03-28","current":-0.37635,"twenty":-4.483193,"median":-1.529496,"eighty":-0.637956,"marketCap":2482077},{"date":"2025-04-04","current":-0.366511,"twenty":-4.411341,"median":-1.523784,"eighty":-0.634433,"marketCap":2417186},{"date":"2025-04-11","current":-0.332098,"twenty":-4.329163,"median":-1.516749,"eighty":-0.632639,"marketCap":2190230},{"date":"2025-04-17","current":-0.351752,"twenty":-4.324001,"median":-1.513745,"eighty":-0.629089,"marketCap":2319850},{"date":"2025-04-23","current":-0.351752,"twenty":-4.272371,"median":-1.506489,"eighty":-0.626317,"marketCap":2319850}],"updateTime":1745492753639}}}